• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cidara Thera (NQ: CDTX )

14.48 +0.58 (+4.17%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,025
Open 14.08
Bid (Size) 13.40 (1)
Ask (Size) 14.85 (1)
Prev. Close 13.90
Today's Range 13.82 - 14.75
52wk Range 10.00 - 24.40
Shares Outstanding 49,506,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
Today 9:07 EST
CDTX sold its Rezayo business to concentrate on its MDC-producing Cloudbreak platform which has already produced several promising drug candidates, like CD388, a very promising clinical-stage... 
Via Talk Markets
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
Via Benzinga

Performance

YTD
-9.58%
-9.58%
1 Month
+40.58%
+40.58%
3 Month
+12.60%
+12.60%
6 Month
+13.93%
+13.93%
1 Year
-8.35%
-8.35%

More News

Read More
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
Via InvestorPlace
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 16, 2024
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 16, 2024
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Cidara Therapeutics (CDTX) Stock Is Falling
April 22, 2024
Via Benzinga
CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via InvestorPlace
CDTX INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX
May 14, 2024
From The Rosen Law Firm PA
Via GlobeNewswire
CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 13, 2024
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
CDTX LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 13, 2024
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
April 25, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via Benzinga
CDTX LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX
April 25, 2024
From The Rosen Law Firm, P.A.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 25, 2024
Via InvestorPlace
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
April 25, 2024
Via Benzinga
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 23, 2024
Via Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023
April 22, 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 30, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 25, 2023
Via Benzinga
Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher
September 06, 2023
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 06, 2023
Via Benzinga
Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 06, 2023
Via Benzinga
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?
September 06, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap